Intravenous immunoglobulins in infantile dyshidrosiform bullous pemphigoid refractory to steroids and dapsone

Dermatol Ther. 2022 Nov;35(11):e15826. doi: 10.1111/dth.15826. Epub 2022 Sep 27.

Authors

Gianmaria Viglizzo¹, Astrid Herzum^{1

2}, Emanuele Cozzani², Corrado Occella¹, Aurora Parodi²

Affiliations

¹ Section of Dermatology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
² Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa, IRCCS San Martino Polyclinic Hospital, Genoa, Italy.

No abstract available

Publication types

Letter

MeSH terms

Dapsone / therapeutic use
Humans
Immunoglobulins, Intravenous / therapeutic use
Pemphigoid, Bullous* / diagnosis
Pemphigoid, Bullous* / drug therapy
Steroids

Substances

Dapsone
Immunoglobulins, Intravenous
Steroids